Regarding liver cancer and except for hepatoblastoma, on which data arise mostly from case reports illustrating notable CRP increases, a dismal prognosis in patients with aggressive hepatocellular carcinoma was linked to elevated CRP at diagnosis (optimal cutoff 10 mg/L), which may lead it to become a useful marker for patient selection and management [19,768,828]. This evidence concerns the gene CRP and liver cancer.